Onxeo

Onxeo is biotechnology company that develops of drugs for oncology. The company was formed after a 2014 merger of BioAlliance Pharma, a French biotechnology company, and TopoTarget, a Danish biotechnology company.[1]

History and product pipeline

See TopoTarget

References

  1. "BioAlliance to Merge With Topotarget in All-Stock Deal". Bloomberg L.P. Retrieved 30 October 2014.
This article is issued from Wikipedia - version of the 11/22/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.